The Banff 97 working classification of renal allograft pathology

Kidney International

Volumn 55, Issue 2, 1999, Pages 713-723

  Racusen, Lorraine C ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae,af}   Solez, Kim ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Colvin, Robert B ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Bonsib, Stephen M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Castro, Maria C ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Cavallo, Tito ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Croker, Byron P ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Demetris, A Jake ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Drachenberg, Cynthia B ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Fogo, Agnes B ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Furness, Peter ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Gaber, Lillian W ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Gibson, Ian W ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Glotz, Dennis ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Goldberg, Julio C ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Grande, Joseph ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Halloran, Philip F ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Hansen, H E ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Hartley, Barry ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Hayry, Pekka J ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Hill, Claire M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Hoffman, Ernesto O ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Hunsicker, Lawrence G ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Lindblad, Anne S ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Marcussen, Niels ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Mihatsch, Michael J ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Nadasdy, Tibor ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Nickerson, Peter ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Olsen, T Steen ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Papadimitriou, John C ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Randhawa, Parmjeet S ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Rayner, David C ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Roberts, Ian ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Rose, Stephen ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Rush, David ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Salinas Madrigal, Luis ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Salomon, Daniel R ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Sund, Stale ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Taskinen, Eero ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Trpkov, Kiril ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   Yamaguchi, Yutaka ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,aa,ab,ac,ad,ae}   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF CINCINNATI   (United States)

^g UNIVERSITY OF FLORIDA   (United States)

^h UNIVERSITY OF PITTSBURGH   (United States)

ⁱ UNIVERSITY OF MARYLAND   (United States)

^j VANDERBILT UNIVERSITY   (United States)

^k UNIVERSITY OF LEICESTER   (United Kingdom)

^l UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^m UNIVERSITY OF GLASGOW   (United Kingdom)

ⁿ HÔPITAL BROUSSAIS   (France)

^o Institute of Pathology   (Argentina)

^p MAYO CLINIC   (United States)

^q AARHUS UNIVERSITY   (Denmark)

^r GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^s UNIVERSITY OF HELSINKI   (Finland)

^t QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^u LOUISIANA STATE UNIVERSITY   (United States)

^v UNIVERSITY OF IOWA   (United States)

^w EMMES CORPORATION   (United States)

^x UNIVERSITY OF BASEL   (Switzerland)

^y UNIVERSITY OF MANITOBA   (Canada)

^z UNIVERSITY OF MANCHESTER   (United Kingdom)

^aa NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^ab SAINT LOUIS UNIVERSITY   (United States)

^ac SCRIPPS RESEARCH INSTITUTE   (United States)

^ad OSLO UNIVERSITY HOSPITAL   (Norway)

^ae JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^af DEPARTMENT OF PATHOLOGY   (United States)

more..

Author keywords

Allograft pathology; Biopsy interpretation; Kidney; Lesion scoring; Transplantation

Indexed keywords

ARTICLE; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; GRAFT REJECTION; HUMAN; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FAILURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032910625     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00299.x     Document Type: Article

References (51)

1. 1. SOLEZ K, AXELSEN RA, BENEDIKTSSON H, BURDICK JF, COHEN AH, COLVIN RB, CROKER BP, DROZ D, DUNNILL MS, HALLORAN PF, HAYRY P, MENNETTE JC, KEOWN PA, MACUSSEN N, MIHATSCH MJ, MOROZUMI K, MYERS BD, NAST CC, OLSEN S, RACUSEN LC, RAMOS EL, ROSEN S, SACHS DH, SALOMON DR, SANFILIPPO F, VERANI R, VON WILLEBRAND E, YAMAGUCHI Y: International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 44:411-422, 1993
2. 2. COREY HE, GREENSTEIN SM, TELLIS V, SCHECHNER R, GREIFER I, BENNETT B: Renal allograft rejection in children and young adults: The Banff classification. Pediatr Nephrol 9:309-312, 1995
3. 3. GABER LW, MOORE LW, ALLOWAY RR, FLAX SD, SHODOUHAMI MH, SCHRODER T, GABER AO: Correlation between Banff classification, acute renal rejection scores and reversal of rejection. Kidney Int 49:481-487, 1996
4. 4. DITTMER ID, ZWI LJ, COLLINS JF: Validation of the Banff Criteria for acute rejection in renal transplant biopsies. Aust N Z J Med 25:681-687, 1995
5. 5. RUSH DN, JEFFREY JR, GOUGH J: Sequential protocol biopsies in renal transplant patients: Clinico-pathological correlations using the Banff schema. Transplantation 59:511-514, 1995
6. 6. GABER LW, SCHROEDER TJ, MOORE LW, SHADOUH-AMIRI MH, GABER AO: The correlation of Banff scoring with reversibility of first and recurrent rejection episodes. Transplantation 61:1711-1715, 1996
7. 7. CROKER BP, CLAPP WL, SHAMAT ARFA, KONE BC, PETERSON JC: Macrophages and chronic renal allograft nephropathy. Kidney Int 50:S42-S49, 1996
8. 8. OLSEN S, HANSEN HE, MADSEN M: Studies of the Clinical Value of the Banff Grading of Acute Rejection, http://www.his.path.cam.ac. uk/mirrors/isn/000i011h.htm. Posted March 13, 1997
9. 9. COLVIN RB, COHEN A, SIAONZ C, BONSIB S, BUICK M, BURKE B, CAVALLO T, HAAS M, LINDBLAD A, NAST C, SPARGO B, WEAVER C, WEISS MA: Evaluation of the pathologic criteria for acute renal allograft rejection: Reproducibility, sensitivity and clinical correlation. J Am Soc Nephrol 8:1930-1941, 1997
10. 10. SOLEZ K, CAVALLO T, CROKER B, et al: Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology. Transplant Proc 28:441-444, 1996
11. 11. TRPKOV K, SOLEZ K: Effect of acute tubulitis and vasculitis on graft loss and early allograft function in patients treated with mycophenolate mofetil. Banff 97 CD-ROM, Saunders-Churchill, 1998
12. 12. NICKELEIT V, VAMVAKES EC, PASCUAL M, POLETTI BJ, COLVIN RJ: The prognostic significance of significant arterial lesions in acute allograft rejection. J Am Soc Nephrol 7:1301-1308, 1998
13. 13. HALLORAN PF: Renal injury and preservation in transplantation, in Kidney Transplant Rejection (vol 3), edited by RACUSEN LC, SOLEZ K, BURDICK JF, New York, Marcel Dekker, 1998, pp 149-176
14. 14. RACUSEN LC, SOLEZ K, OLSEN S: The pathology of kidney transplantation, in Kidney Transplant Rejection (vol 3), edited by RACUSEN LC, SOLEZ K, BURDICK JF, New York, Marcel Dekker, 1998, pp 383-418
15. 15. RAUL LC, HAYRY P, FOEGH M, DENNIS MJ, MIHATSCH MJ, LARSSON E, FELLSTROM B: Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants. Transplant Proc 25:2022-2023, 1993
16. 16. MIHATSCH JM, RYFFEL B, GUDAT F: Morphological criteria of chronic rejection: Differential diagnosis, including cyclosporine nephropathy. Transplant Proc 25:2031-2037, 1993
17. 17. SOLEZ K, RACUSEN LC, MIHATSCH M: Nephrotoxicity of cyclosporine and newer immunosuppressive agents, in Solid Organ Allograft Rejection, edited by SOLEZ K, RACUSEN LC, BILLINGHAM M, New York, Marcel Dekker, 1996, pp 587-620
18. 18. MIHATSCH MJ: Histopathology of chronic rejection. (abstract) XVII World Congress, The Transplantation Society, Montreal, July 12-17, 1998
19. 19. FINKELSTEIN FO, SIEGEL NJ, BASTL C, FORSEST JNJ, KASHGARIAN M: Kidney transplant biopsies in the diagnosis and management of acute rejection reactions. Kidney Int 10:171-178, 1976
20. 20. BANFI G, IMBASCIATI E, TARANTINO A, PONTICELLI C: Prognostic value of renal biopsy in acute rejection of kidney transplantation. Nephron 28:222-226, 1981
21. 21. MATAS AJ, SIBLEY R, MAUER M, SUTHERLAND DE, SIMMONS RL, NAJARIAN JS: The value of needle renal allograft biopsy. I. A retrospective study of biopsies performed during putative rejection episodes. Ann Surg 197:226-237, 1983
22. 22. VISSCHER D, CAREY J, OH H, TURZA N, KUPIN W, VENKAT KK, ZARBO R: Histologic and immunophenotypic evaluation of pre-treatment renal biopsies in OKT3-treated allograft rejections. Transplantation 51:1023-1028, 1991
23. 23. SCHROEDER TJ, WEISS MA, SMITH RD, STEPHENS GW, FIRST MR: The efficacy of OKT3 in vascular rejection. Transplantation 51:312-315, 1991
24. 24. BURDICK JF, BESCHORNER WE, SMITH WJ, MCGRAW DJ, BENDER WL, WILLIAMS GM, SOLEZ K: Characteristics of early routine renal allograft biopsies. Transplantation 38:679-684, 1984
25. 25. SOLEZ K, RACUSEN LC, MARCUSSEN N, SLATNIK I, KEOWN P, BURDICK JF, OLSEN S: Morphology of ischemic acute renal and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney Int 43:1058-1067, 1993
26. 26. RUSH D, JEFFREY J, TRPKOV K, SOLEZ K, GOUGH J: Effect of subclinical rejection on renal allograft histology and function at 6 months. Transplant Proc 18:494-495, 1996
27. 27. RUSH D, NICKERSON P, MCKENNA RM, GRIMM PC, CHEANG M, TRPKOV K, SOLEZ K, JEFFREY R: Beneficial effects of treatment of early subclinical rejection: A randomized study. J Am Soc Nephrol 7:2129-2134, 1998
28. 28. SCHWEITZER EJ, DRACHENBERG CB, ANDERSON L, PAPADMETRIOU JC, KUO PC, JOHNSON LB, KLASSEN DK, HOEHN-SARIC E, WEIR MR, BARTLETT ST: Significance of the Banff borderline biopsy. Am J Kidney Dis 28:585-588, 1996
29. 29. MORRISSEY PE, GOH R, SHAFFER D, CROSSON A, MADRAS PN, SAHYOUN AI, MONACO AP: Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Transplantation 63:845-848, 1997
30. 30. SAAD R, GRITSCH HA, SHAPIRO R, JORDAN M, VIVAS C, SCANTLEBURY V, DEMETRIS AJ, RANDHAWA PS: Clinical significance of renal allograft biopsies with "borderline changes," as defined in the Banff schema. Transplantation 64:992-995, 1997
31. 31. FURNESS PN, KIRKPATRICK U, TAUB N, DAVIES DR, SOLEZ K: A UK-wide trial of the Banff classification of renal transplant pathology in routine diagnostic practice. Nephrol Dial Transplant 12:995-1000, 1997
32. 32. TANABE K, TAKAHASHI K, SONDA K, ONITSUKA S, YAMAGUCHI I: Clinicopathologic analysis of rejection episodes in ABO-incompatible kidney transplantation. Transplant Proc 28:1447-1448, 1996
33. 33. TRPKOV K, CAMPBELL P, PAZDERKA F, COCKFIELD S, SOLEZ K, HALLORAN PF: The significance of the anti-class I response II: Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 53:550-555, 1992
34. 34. BOHLE A, WEHRMANN M, BOGENSCHUTZ O, BATZ C, VOGL W, SCHMITT H, MULLER CA, MULLER GA: The long-term prognosis of the primary glomerulonephritides: A morphological and clinical analysis of 1748 cases. Pathol Res Pract 188:908-924, 1992
35. 35. ISONIEMI HM, TASKINEN E, HAYRY P: Histopathologic chronic allograft damage index accurately predicts chronicrenal allograft rejection. Transplantation 58:1195-1198, 1994
36. 36. PLATT JL, SIBLEY RK, MICHAEL AF: Interstitial nephritis associated with cytomegalovirus infection. Kidney Int 28:550-552, 1985
37. 37. PAPPO O, DEMETRIS AJ, RAIKOW RB, RANDHAWA PS: Human polyoma virus infection of renal allografts: Histopathologic diagnosis, clinical significance and literature review. Mod Pathol 9:105-109, 1996
38. 38. ITO M, HIRABAYASH N, UNO Y, NAKAYAMA AJA: Necrotizing tubulointerstitial nephritis associated with adenovirus infection. Hum Pathol 22:1225-1231, 1991
39. 39. COLVIN RB: The renal allograft biopsy. Kidney Int 50:1069-1082, 1996
40. 40. RANDHAWA PS, DEMETRIS AJ, PIETRZAK B, NALESNIK MA: Histopathology of renal post-transplant lymphoproliferation: Comparison with rejection using the Banff Schema. Am J Kidney Dis 28:578-584, 1996
41. 41. TRPKOV K, MARCUSSEN N, RAYNER D, LAM G, SOLEZ K: Kidney allograft rejection, post-transplant lymphoproliferative disorder, neither, or both entities. Am J Kidney Dis 30:449-454, 1997
42. 42. DEAMANT FD, ALBUJAR PF, CHEN YY, WEISS LM: Epstein-Barr virus distribution in neoplastic lymph nodes. Mod Pathol 6:729-732, 1993
43. 43. SEIDEN MV, SKLAR J: Molecular genetic analysis of posttransplant lymphoproliferative disorders. Hematol Oncol Clin North Am 7:447-465, 1993
44. 44. RANDHAWA PS, SHAPIRO R, JORDAN ML, STARZL TE, DEMETRIS AJ: The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Am J Surg Pathol 17:60-68, 1993
45. 45. JAPANESE FK506 STUDY GROUP: Morphological characteristics of renal allografts showing renal dysfunction under FK506: Is graft biopsy available to reveal the morphological findings corresponding with FK506 nephropathy? Transplant Proc 25:624-627, 1993
46. 46. RANDHAWA PS, TSAMANDAS AC, MAGNONE M, JORDAN M, SHAPIRO R, STARZL TE, DEMETRIS AJ: Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy. Am J Surg Pathol 20:306-312, 1996
47. 47. RANDHAWA PS, STARZL TE, DEMETRIS AJ: Tacrolimus (FK506) associated renal pathology. Adv Anat Pathol 4:265-276, 1997
48. 48. STILLMAN IE, ANDOH TF, BURDMANN EA, BENNETT WM, ROSEN S: FK506 nephrotoxicity: Morphologic and physiologic characterization of a rat model. Lab Invest 73:794-803, 1995
49. 49. SERON D, MORESO F, BOVER J, CONDOM E, GIL-VERNET S, CANAS C, FULLADOSA X, TORRAS J, CARRERE M, GRINYO JM, ALSINA J: Early protocol renal allograft biopsies and graft outcome. Kidney Int 51:310-316, 1997
50. 50. NICKERSON P, JEFFERY J, MCKENNA R, GRIMM P, CHANG M, RUSH D: Identification of clinical and histopathologic risk factors for diminished renal function 2 years post-transplant. J Am Soc Nephrol 19:482-487, 1998
51. 51. STREHLAU J, PAVLAKIS M, LIPMAN M, SHAPIRO M, VASCONCELLOS L, HARMON W, STROM TB: Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 94:695-700, 1997